BioSpace News Archive

Press Releases

Exelixis Announces Detailed Results from Phase 3 STELLAR-303 Pivotal Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer Presented at ESMO 2025 and Published in The Lancet

October 20, 2025
·
10 min read
Press Releases

Genentech’s Tecentriq Showed Significant Overall and Disease-Free Survival Benefits in Bladder Cancer With ctDNA-Guided Treatment

October 20, 2025
·
12 min read
Press Releases

New Needle-Free Treatment Option for Life-Threatening Anaphylaxis, EURneffy®, Now Available in the UK

October 20, 2025
·
8 min read
Press Releases

CatalYm Presents Long-Term Phase 1/2a Data Confirming Sustained Responses with Visugromab in CPI-Refractory Tumors at ESMO 2025

October 20, 2025
·
5 min read
Press Releases

Caranx Medical (CarvOlix group) to Showcase Latest Updates at the 37th Annual Transcatheter Cardiovascular Therapeutics® Conference (TCT)

October 20, 2025
·
2 min read
Press Releases

FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis

October 20, 2025
·
12 min read
Press Releases

Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors

October 20, 2025
·
9 min read
Press Releases

Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients

October 20, 2025
·
5 min read
Press Releases

Iksuda Presents Encouraging IKS014 Phase 1 Data at ESMO

October 20, 2025
·
4 min read
Press Releases

Immunotherapy After Surgery Shows Promise in Treating Rare, Aggressive Skin Cancer

October 20, 2025
·
5 min read